- When:
- Tuesday March 28th, 11:45AM to 12:45PM
- Where:
- Light Hall 202
- Topic
- How does the role of government affect your efforts to develop new innovative medical technologies?
Please join us for a Lunch & Learn on March 28 from 11:45AM – 12:45PM to discuss the impact of federal policies, processes and programs on inventors and researchers like you! We invite you to join representatives from AdvaMed Accel to learn of the latest developments from Washington and beyond that are affecting the medical device commercialization lifecycle including:
- New opportunities to work with FDA
- The increasing importance of a reimbursement strategy and demonstrating value
- Best practices for working with government agencies
- Capital formation – including NIH funding
- The AdvaMed Affiliate Membership (available to inventors and researches at Vanderbilt)
- Other issues of importance for Vanderbilt medical device entrepreneurs.
The program will also touch on current opportunities and threats to the MedTech innovation ecosystem and how AdvaMed is working to reduce risk with government agencies and private payers to allow your ideas and companies to grow.
Lunch will be provided by the Center for Technology Transfer and Commercialization (CTTC)
AdvaMed Accel is the division within AdvaMed dedicated to addressing the unique needs and challenges of smaller medical device and diagnostics manufacturers – the lifeblood of the medical technology industry. The only organization of its kind focusing specifically on the needs of the medtech industry’s emerging growth companies, AdvaMed Accel works to create a policy environment more conducive to capital formation and innovation. For more information, visit www.advamedaccel.org.
About the speaker:
Ashley Wittorf is executive director of AdvaMed Accel, the division within AdvaMed dedicated to accelerating the growth and success of smaller medical device and diagnostics manufacturers. Leveraging the resources of the entire association, AdvaMed Accel is the only organization of its kind focused specifically on addressing the unique needs and challenges of emerging and early growth enterprises – the lifeblood of the medical technology industry.
As executive director of AdvaMed Accel, Wittorf serves as the voice of entrepreneurial small companies that are providing innovative health care solutions through earlier disease detection, less invasive procedures and more effective treatments, to help people live longer, healthier lives. AdvaMed Accel provides advocacy for a policy environment more conducive to capital formation and innovation; insight into ever-changing regulatory, reimbursement, compliance and business environments; and opportunity for member engagement with peers, subject matter experts and policymakers, to help small companies prosper.
Wittorf joined AdvaMed in 2012 after nearly a decade in business development and engineering roles in the medical device and pharmaceutical industries, focusing on product development, commercialization strategy, and operations, with both small, venture-backed enterprises and large corporations.
Wittorf serves on the board of directors of MedTech Innovator, the MedTech industry’s nonprofit accelerator and venture competition. She holds a master’s degree in bioengineering and a bachelor’s degree in mechanical engineering from the Georgia Institute of Technology, and a Master of Business Administration degree from the University of Virginia’s Darden School of Business.